Background Maternal tetanus-diphtheria-and-acellular-pertussis (Tdap) vaccination is
offered to all pregnant women during their second trimester in the Netherlands since …

Background The current obstetrical recommendation is to routinely administer the tetanus,
diphtheria, and acellular pertussis (Tdap) vaccination during every pregnancy regardless of …

The objective of this study was to evaluate the safety of prenatal tetanus, diphtheria,
acellular pertussis (Tdap) vaccination. This cohort study was conducted among pregnant …

Background A maternal tetanus-diphtheria-and-acellular-pertussis (Tdap) vaccine is offered
to all pregnant women in the Netherlands in their second trimester since December 2019 …

ABSTRACT The “Adacel (Tdap5) Pregnancy Registry” was used to identify 1182 women
who received the tetanus, diphtheria, acellular pertussis [5 components](Tdap5) vaccine …

Objectives Actively recruit and intensively follow pregnant women receiving a dose of
acellular pertussis vaccine for 4 weeks after vaccination. Design and settings A prospective …

Objective The CDC's Advisory Committee on Immunization Practices recommends
administration of Tdap vaccine during each pregnancy to provide passive immunity for …

Abstract Background New Zealand has funded the administration of tetanus, diphtheria and
acellular pertussis (Tdap) vaccine during pregnancy to prevent infant pertussis since 2013 …

OBJECTIVE: To evaluate pregnancy outcomes of women who received tetanus, diphtheria,
and acellular pertussis (Tdap) vaccination at or after 32 weeks of gestation. Outcomes from …

Abstract Introduction Since October 2012, the combined tetanus toxoid, reduced diphtheria
toxoid, acellular pertussis vaccine (Tdap) has been recommended in the United States …